Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Proteases and phosphatases are important enzymes in a variety of biochemical pathways in living cells. Proteases are required for many cellular functions, including cellular repair and the digestion of extracellular material. Phosphatases play a key role in regulating signal transduction events in eukaryotic cells. Protein kinases transfer a phosphate from ATP to a serine, threonine, or tyrosine residue in a protein; phosphatases remove the phosphoryl group. Phosphorylation is the most common post-translational modification on proteins, with approximately 80% occurring on serine, 20% on threonine, and 0.1 to 1% on tyrosine residues.
All living organisms contain proteolytic enzymes (proteases and peptidases). In whole cells, protease and phosphatase activities are tightly regulated by compartmentalization or inhibitors to prevent indiscriminate damage to cellular proteins and to maintain proper function of signaling pathways. Cell lysis disturbs the carefully controlled cellular environment, allowing proteases and phosphatases to become unregulated. The usual consequence of this unregulated state is reduced recovery of total protein and biologically meaningless representation of protein activities (i.e., phosphorylation status).
Protease inhibitors are biological or chemical compounds that function by reversibly or irreversibly binding to the protease. Most known proteases belong to one of four evolutionarily distinct enzyme families based on the functional groups involved in cleavage of the peptide bond. Known phosphatases are specific for cleavage of either serine-threonine or tyrosine phosphate groups. Thus, while numerous compounds have been identified and used to inactivate or block these enzymes, no single chemical is effective for all types of proteases and phosphatases (see tables below). Rather, a mixture or inhibitor cocktail of several different inhibitor compounds are used to ensure that protein extracts do not degrade before analysis for targets of interest. Proteases inhibitors are nearly always needed, while phosphatase inhibitors are required only when phosphorylation states (activation states) are being investigated. Research experiments may necessitate the use of single inhibitors or customized mixtures, but most protein work is best served by using a suitable protease inhibitor cocktail.
Inhibitor | MW (kDa) | Target class | Type | Solubility (solvent) | Typical working (1X) conc. |
---|---|---|---|---|---|
AEBSF | 239.5 | Serine proteases | Irreversible | 200 mg/mL (H2O) | 0.2 to 1.0 mM |
Aprotinin | 6511.5 | Serine proteases | Reversible | 10 mg/mL (H2O) | 100 to 200 nM |
Bestatin | 308.4 | Amino-peptidases | Reversible | 5 mg/mL (MeOH) | 1 to 10 µM |
E-64 | 357.4 | Cysteine proteases | Irreversible | 20 mg/mL (1:1 EtOH:H2O) | 1 to 20 µM |
EDTA | 372.2 | Metalloproteases (chelates cations) | Reversible | 10 g/100 mL (H2O) | 2 to 10 mM |
Leupeptin | 475.6 | Serine and cysteine proteases | Reversible | 1 mg/mL (H2O) | 10 to 100 µM |
Pepstatin A | 685.9 | Aspartic acid proteases | Reversible | 1 mg/mL (MeOH) | 1 to 20 µM |
PMSF | 174.2 | Serine proteases | Reversible | 18 mg/mL (MeOH) | 0.1 to 1.0 mM |
Inhibitor | MW (kDa) | Target class | Type | Solubility (solvent) | Typical working (1X) conc. |
---|---|---|---|---|---|
Sodium fluoride | 42.0 | Ser/Thr and acidic phosphatases | Irreversible | 40 mg/mL (H2O) | 1 to 20 mM |
Sodium orthovanadate | 183.9 | Tyr and alkaline phosphatases | Irreversible | 20 mg/mL (H2O) | 1 to 100 mM |
beta-Glycerophosphate (Disodium salt) | 216.0 | Ser/Thr phosphatases | Reversible | 10 mg/mL (H2O) | 1 to 100 mM |
Sodium pyrophosphate | 221.9 | Ser/Thr phosphatases | Irreversible | 65 mg/mL (H2O) | 1 to 100 mM |
Comparison of commercially available protease inhibitor cocktails and tablets. Pancreatic extract (50 μL, 1 μg/μL protein) or trypsin (25 μL, 0.1 units/μL) was incubated with a quenched-fluorescent, protease-cleavable substrate for cysteine (A) or serine proteases (B) in the presence or absence of commercially available protease inhibitors with EDTA-containing (blue) or EDTA-free (purple) formulations. Reactions were incubated for 2 hours at 37°C and the fluorescence determined at indicated detecting emissions. The percent protease inhibition is shown for each protease inhibitor formulation.
For Research Use Only. Not for use in diagnostic procedures.